The agreement covers GynTect, which uses epigenetic biomarkers and methylation-specific PCR to determine if an HPV-positive patient is at risk for developing cervical cancer.
The deal gives SouthGenetics marketing rights for MDxHealth's ConfirmMDx test for prostate cancer in 12 countries, including Mexico, Argentina, and Colombia.
The deal will provide researchers a fully automated solution for immunostaining captured circulating tumor cells deposited on microscope slides.
The deal provides customers a complete end-to-end solution for cytogenomic array and next-generation sequencing services, the firms said.
The partners will co-market the Phenomenex Strata and Strata-X SPE sorbents adapted to Tecan's Freedom EVO series of robotic workstations.
Under the agreement, customers will be able to purchase GeneSeek Genomic Profiler SNP arrays from Illumina, initially for genotyping cattle, pigs, and horses.
Under the terms of the agreement, Tataa will distribute and support Strand's analysis software in Europe and will also use the tool in training programs.
Thermo Fisher will market Horizon's X-MAN human haploid and diploid isogenic cell line collection.
Under the terms of the agreement, Sciex has exclusive reseller and marketing rights to the XCMSplus software.
The partners will jointly promote the BD FACS single-cell sorting instrument alongside Cellular Research's molecular bar-coding technology, Precise.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.